High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-16556-2.pdf
Reference42 articles.
1. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893–2917, https://doi.org/10.1002/ijc.25516 (2010).
2. Bill-Axelson, A. et al. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur. Urol 64, 920–928, https://doi.org/10.1016/j.eururo.2013.02.025 (2013).
3. Etzioni, R. et al. Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Clin. Cancer Res 18, 6742–6747, https://doi.org/10.1158/1078-0432.CCR-12-1537 (2012).
4. Fossa, S. D. et al. Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience. Urology 83, 146–152, https://doi.org/10.1016/j.urology.2013.08.081 (2014).
5. Van der Kwast, T. H. & Roobol, M. J. Defining the threshold for significant versus insignificant prostate cancer. Nature reviews. Urology 10, 473–482, https://doi.org/10.1038/nrurol.2013.112 (2013).
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. microRNA-205 in prostate cancer: Overview to clinical translation;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-11
2. MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?;Andrology;2022-08-21
3. miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells;CELL J;2022
4. Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study;Cancers;2022-02-23
5. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data;British Journal of Cancer;2022-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3